Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
RCT
ACE Report #8941
Ace Report Cover Metabolic Disorders

Efficacy of zoledronic acid following PLIF in patients with osteoporosis


Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion

Osteoporos Int. 2016 Apr;27(4):1469-76

Contributing Authors: F Chen Z Dai Y Kang G Lv ET Keller Y Jiang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

79 patients with osteoporosis scheduled for instrumented posterior lumbar interbody fusion due to single-level degenerative spondylolisthesis were randomized to be postoperatively administered either zoledronic acid or saline. The purpose of this study was to compare groups based on fusion status, the incidence of a subsequent vertebral compression fracture, clinical outcome, serum biomarkers of b...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.